LINCOLN PHARMACEUTICALS LTD. (LINCOLN)

Current Price: ₹0.00

Back to Home
Stock Performance

Quarterly Financials

Consolidated Standalone
Particulars Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Revenue from Operations 112.46 135.62 155.99 146.45 142.49 147.28 161.21 146.55 168.18 154.07 163.36 166.32
YOY Revenue Growth % 9.67% 9.84% 10.93% 9.48% 26.71% 8.6% 3.35% 0.07% 18.03% 4.61% 1.33% 13.49%
Other Income 3.95 7.69 8.69 11.02 7.02 10.41 9.98 8.97 -6.88 15.27 7.23 15.15
Total Income 116.41 143.31 164.68 157.47 149.51 157.69 171.19 155.52 161.30 169.34 170.60 181.47
Total Expenses + 81.33 93.76 100.68 106.58 102.42 107.06 117.64 104.41 145.06 133.95 141.79 146.75
Cost of Materials Consumed 33.97 42.70 49.66 56.88 51.89 52.75 57.10 50.16 53.93 60.97 57.20 47.68
Employee Benefit Expense 23.05 26.47 24.94 26.44 25.05 29.02 27.84 27.98 27.62 31.76 30.36 30.62
Other Expenses 24.31 24.59 26.07 23.26 25.48 25.29 32.71 26.27 33.69 29.12 30.83 36.15
Operating Profit 31.13 41.86 55.31 39.87 40.07 40.23 43.57 42.14 23.13 20.12 21.58 19.58
OPM % 27.7% 30.9% 35.5% 27.2% 28.1% 27.3% 27% 28.8% 13.8% 13.1% 13.2% 11.8%
Profit Before Tax + 16.98 25.45 36.87 37.71 22.22 29.48 34.78 28.68 16.25 35.39 28.81 34.72
Tax Expense 4.42 6.43 9.21 9.67 3.62 5.81 8.45 7.91 4.67 7.71 8.83 6.12
Tax % 26% 25.3% 25% 25.6% 16.3% 19.7% 24.3% 27.6% 28.8% 21.8% 30.6% 17.6%
Profit After Tax 12.56 19.01 27.65 28.04 18.60 23.67 26.33 20.77 11.58 27.68 19.98 28.60
EPS (Basic) 6.27 9.49 13.81 14.00 9.28 11.82 13.15 10.37 5.78 13.82 9.98 14.28

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2018
Revenue from Operations 623.23 580.55 510.31 472.08 413.06 376.09 325.51
YOY Revenue Growth % 7.35% 13.76% 8.1% 14.29% 9.83% 15.54% -
Other Income 22.48 34.42 22.48 10.00 6.77 12.13 5.80
Total Income 645.71 614.97 532.79 482.08 419.82 388.22 331.32
Total Expenses + 536.52 403.43 356.74 316.51 226.36 231.91 171.98
Cost of Materials Consumed 213.94 201.12 177.00 158.48 95.50 101.97 63.59
Employee Benefit Expense 112.45 102.90 93.16 70.47 56.47 54.90 47.51
Other Expenses 117.96 99.40 86.59 87.56 74.38 75.04 60.88
Operating Profit 86.71 177.12 153.57 155.57 186.70 144.18 153.53
OPM % 13.9% 30.5% 30.1% 33% 45.2% 38.3% 47.2%
Profit Before Exceptional 109.19 122.24 100.46 95.93 81.01 64.05 43.10
Exceptional Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Profit Before Tax + 109.19 122.24 100.46 95.93 81.01 64.05 43.10
Tax Expense 26.84 28.94 27.56 26.57 20.61 14.48 10.34
Tax % 24.6% 23.7% 27.4% 27.7% 25.4% 22.6% 24%
Profit After Tax 82.35 93.30 72.90 69.36 60.41 49.56 32.76
EPS (Basic) 41.11 46.58 36.40 34.63 30.20 24.78 16.38

Balance Sheet

Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2018
ASSETS
Non-Current Assets + 297.12 253.60 220.26 0.00 0.00 0.00 0.00
Property, Plant & Equipment 181.53 179.00 150.23 0.00 0.00 0.00 0.00
Capital Work in Progress 4.47 3.48 6.71 0.00 0.00 0.00 0.00
Non-Current Investments 0.05 0.05 0.05 0.00 0.00 0.00 0.00
Goodwill 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Intangible Assets 0.44 0.33 0.29 0.00 0.00 0.00 0.00
Current Assets + 499.75 446.55 367.00 0.00 0.00 0.00 0.00
Inventories 78.68 77.17 70.03 0.00 0.00 0.00 0.00
Trade Receivables 165.53 160.90 135.47 0.00 0.00 0.00 0.00
Cash and Cash Equivalents 12.97 5.31 4.58 0.00 0.00 0.00 0.00
Current Investments 173.72 138.92 91.33 0.00 0.00 0.00 0.00
LIABILITIES & EQUITY
Total Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Equity Share Capital 20.03 20.03 20.03 0.00 0.00 0.00 0.00
Other Equity 651.64 572.81 482.44 0.00 0.00 0.00 0.00
Non-Current Liabilities 19.12 15.18 12.66 0.00 0.00 0.00 0.00
Current Liabilities 106.08 92.14 72.12 0.00 0.00 0.00 0.00
Total Liabilities 125.20 107.31 84.78 0.00 0.00 0.00 0.00

Cash Flow Statement

Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2018
Cash from Operating Activities 93.02 63.24 39.16 76.18 0.00 0.00 0.00
Cash from Investing Activities -78.95 -57.34 -36.64 -78.08 0.00 0.00 0.00
Cash from Financing Activities -6.40 -5.18 -4.50 -2.56 0.00 0.00 0.00
Net Increase/Decrease in Cash 7.67 0.73 -1.99 -4.46 0.00 0.00 0.00